Personal information

Activities

Collapse all

Works (3)

The genomic and molecular landscape of splenic marginal zone lymphoma, biological and clinical implications

Exploration of Targeted Anti-tumor Therapy
2024-07-23 | Journal article
DOI: 10.37349/etat.2024.00253
Contributors: Amatta Mirandari; Helen Parker; Margaret Ashton-Key; Benjamin Stevens; Renata Walewska; Kostas Stamatopoulos; Dean Bryant; David G. Oscier; Jane Gibson; Jonathan C. Strefford
Source: check_circle
Crossref

Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type diffuse large B-cell lymphoma

Blood Advances
2023-03-14 | Journal article
DOI: 10.1182/bloodadvances.2022007536
Contributors: Findlay Bewicke-Copley; Koorosh Korfi; Shamzah Araf; Brendan Hodkinson; Emil Kumar; Thomas Cummin; Margaret Ashton-Key; Sharon Barrans; Suzan van Hoppe; Cathy Burton et al.
Source: check_circle
Crossref

Prognostic significance of FCGR2B expression for the response of DLBCL patients to rituximab or obinutuzumab treatment

Blood Advances
2021-08-10 | Journal article
DOI: 10.1182/bloodadvances.2021004770
Contributors: Malgorzata Nowicka; Laura K. Hilton; Margaret Ashton-Key; Chantal E. Hargreaves; Chern Lee; Russell Foxall; Matthew J. Carter; Stephen A. Beers; Kathleen N. Potter; Christopher R. Bolen et al.
Source: check_circle
Crossref
How many people are using ORCID?